top of page
Browse by category
Search
Journal Watch 4/12/2024
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
IFSO publishes consensus paper on the role of obesity management medications before and after metabolic bariatric surgery
The International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) has published an international consensus position...
One in seven Medicare beneficiaries with high BMI and established CVD may qualify for OMMs adding $34 billion to costs
Current federal regulation restricts Medicare from covering obesity management medications (OMMs) prescribed solely for weight loss....
The role of obesity management medications and metabolic and bariatric surgery – an IFSO Consensus Meeting (Module III)
Module III: The future Obesity management medications & metabolic surgery perspectives on cost-effectiveness In the first presentation in...
The role of obesity management medications and metabolic and bariatric surgery – an IFSO Consensus Meeting (Module I)
Despite the huge interest in the newer generation of obesity management medications (OMMs), there is limited knowledge about the impact...
The role of obesity management medications and metabolic and bariatric surgery – an IFSO Consensus Meeting (Module II)
Module II: Use of OMMs after MBS Combined medical-surgical treatment of obesity In the first presentation of the second module by...
Browse by tag
bottom of page